| RS2145140145 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2145140504 |
GGN
|
Health Risk |
Pathogenic |
Spermatogenic failure 69, Spermatogenic failure 69 |
| RS2145142389 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145142832 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2145143911 |
ELANE
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS2145144118 |
ELANE
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS2145144144 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2145145006 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS2145145135 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2145147131 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2145148405 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutropenia, severe congenital |
| RS2145148773 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutropenia, severe congenital |
| RS2145148879 |
ELANE
|
Health Risk |
Pathogenic |
— |
| RS2145148969 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2145149093 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Cyclical neutropenia, Neutropenia |
| RS2145149526 |
ELANE
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS2145149748 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2145149815 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2145169684 |
PGAP3
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2145173097 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2145173322 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145175361 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2145180670 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145182512 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145184643 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2145190803 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2145191308 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS2145191473 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS2145191499 |
NFIX
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2145191618 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS2145191691 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS2145191753 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS2145191979 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2145192041 |
NFIX
|
Health Risk |
Likely pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS2145192459 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2145192509 |
NFIX
|
Health Risk |
Conflicting classifications of pathogenicity |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS2145192570 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2145192572 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2145192745 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2145192782 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS2145192793 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2145192919 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS2145210376 |
INSR
|
Health Risk |
Likely pathogenic |
— |
| RS2145221516 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145223302 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS2145224416 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145225250 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145225515 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145225759 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145230737 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145231253 |
TAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145232021 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145232689 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145232776 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145232912 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145235661 |
TAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145236067 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145236177 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2145238905 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS2145239459 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145239498 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145241576 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145242241 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145242325 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS2145243385 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145243883 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145244590 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2145244734 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Inborn genetic diseases |
| RS2145245078 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS2145245242 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145245392 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2145245448 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145245505 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2145245595 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Spinocerebellar ataxia type 6 |
| RS2145247321 |
BCAS3
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2145248615 |
ATCAY
|
Health Risk |
Pathogenic |
Cayman type cerebellar ataxia, Cayman type cerebellar ataxia |
| RS2145250103 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145250113 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145251876 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145252486 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2145253354 |
DNMT1
|
Health Risk |
Likely pathogenic |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS2145253412 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145253737 |
DNMT1
|
Health Risk |
Pathogenic |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS2145253839 |
ASXL3
|
Health Risk |
Likely pathogenic |
— |
| RS2145254041 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145254277 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145254657 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145256406 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145256501 |
ATCAY
|
Health Risk |
Pathogenic |
— |
| RS2145256753 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145256864 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2145258173 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2145258726 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2145258824 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2145258835 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2145258913 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2145259879 |
TYK2
|
Health Risk |
Likely pathogenic |
— |
| RS2145261406 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS2145261721 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS2145261985 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |